GNI Group Ltd
TSE:2160
GNI Group Ltd
Operating Income
GNI Group Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
GNI Group Ltd
TSE:2160
|
Operating Income
¥5.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Operating Income
¥6.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Operating Income
¥1.5B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-2%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Operating Income
¥6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
47%
|
CAGR 10-Years
48%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Operating Income
-¥155.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
17%
|
S
|
StemRIM Inc
TSE:4599
|
Operating Income
¥142.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is GNI Group Ltd's Operating Income?
Operating Income
5.2B
JPY
Based on the financial report for Dec 31, 2023, GNI Group Ltd's Operating Income amounts to 5.2B JPY.
What is GNI Group Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
55%
Over the last year, the Operating Income growth was 342%. The average annual Operating Income growth rates for GNI Group Ltd have been 44% over the past three years , 55% over the past five years .